Gene proriling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support

被引:80
|
作者
Birks, EJ
Hall, JL
Barton, PJR
Grindle, S
Latif, N
Hardy, JP
Rider, JE
Banner, NR
Khaghani, A
Miller, LW
Yacoub, MH [1 ]
机构
[1] Royal Brompton & Harefield Hosp, Heart Sci Ctr, Harefield UB9 6JH, Middx, England
[2] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Heart Sci Ctr, London SW7 2AZ, England
[3] Univ Minnesota, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA
关键词
heart failure; heart-assist device; myocardial contraction; remodeling; genes;
D O I
10.1161/CIRCULATIONAHA.104.526137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-After left ventricular-assist device (LVAD) support, a proportion of patients recover sufficient ventricular function to enable explantation of the device. The exact molecular mechanisms involved in myocardial recovery remain unknown. Cytoskeletal proteins are essential for the structure and function of the cardiac myocyte and might play a major role. Methods and Results-A total of 15 patients with nonischemic cardiomyopathy who required LVAD implantation were studied; 6 recovered sufficiently to allow explantation of the device compared with 9 who did not recover and required transplantation. LV myocardial samples were collected at implantation and explantation/transplantation. Affymetrix microarray analysis was performed on the paired samples and analyzed with reference to sarcomeric and nonsarcomeric cytoskeletal proteins. In the recovery group, of the nonsarcomeric proteins, lamin A/C increased 1.5-fold (P < 0.05) and spectrin 1.6-fold (P < 0.05) between the times of implantation and explantation. Integrins beta 1, beta 6, and alpha 7 decreased 1.7-fold (P < 0.05), 2.4-fold (P < 0.05), and 1.5-fold (P < 0.05), respectively, but integrins alpha 5 and beta 5 increased 2.3-fold (P < 0.01) and 1.2-fold (P < 0.01) at explantation. The following sarcomeric proteins changed in the recovered group only: beta-actin increased 1.4-fold (P < 0.05); a-tropomyosin, 1.3-fold (P < 0.05); alpha 1-actinin, 1.8-fold (P < 0.01); and alpha-filarnin A, 1.6-fold (P < 0.05). Both troponin T3 and alpha 2-actinin decreased by 1.6-fold at the time of explantation (P<0.05). Vinculin decreased 1.7-fold (P=0.001) in the recovered group but increased by 1.7-fold (P<0.05) in the nonrecovered group. Vinculin protein levels decreased 4.1-fold in the recovered group. Conclusions-Myocardial recovery was associated with a specific pattern of changes in sarcomeric, nonsarcomeric, and membrane-associated proteins, which could have important implications in understanding the mechanisms involved.
引用
收藏
页码:I57 / I64
页数:8
相关论文
共 50 条
  • [21] Vancomycin Use During Left Ventricular Assist Device Support
    Eyler, Rachel F.
    Butler, Simona O.
    Walker, Paul C.
    DePestel, Daryl D.
    Spoor, Martinus T.
    Pagani, Francis D.
    Malani, Preeti N.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (05): : 484 - 486
  • [22] Left ventricular function during support with an asynchronous pulsatile left ventricular assist device
    Dalby, MCD
    Banner, NR
    Tansley, P
    Grieve, LA
    Partridge, J
    Yacoub, MH
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (03): : 292 - 300
  • [23] Impact of Sacubitril/valsartan on Clinical Outcomes During Left Ventricular Assist Device Support
    Imamura, Teruhiko
    ASAIO JOURNAL, 2022, 68 (02) : E37 - E37
  • [24] Changes in Right Ventricular Function During Continuous-low Left Ventricular Assist Device Support
    Maeder, Micha T.
    Leet, Angeline
    Ross, Andrew
    Esmore, Donald
    Kaye, David M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (04): : 360 - 366
  • [25] Outcomes After Extracorporeal Right Ventricular Assist Device Combined With Durable Left Ventricular Assist Device Support
    Khorsandi, Maziar
    Schroder, Jacob
    Daneshmand, Mani
    Bishawi, Muath
    Bouamra, Omar
    Winterton, Patrick
    Choi, Ashley Y.
    Patel, Chetan
    Rogers, Joseph
    Del Rio, J. Mauricio
    Milano, Carmelo
    ANNALS OF THORACIC SURGERY, 2019, 107 (06): : 1768 - 1774
  • [26] Clinical, Molecular, and Genomic Changes After Left Ventricular Assist Device Implantation Reply
    Hall, Jennifer L.
    Miller, Leslie W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (24) : 2460 - 2460
  • [27] Changes in Spirometry After Left Ventricular Assist Device Implantation
    Mohamedali, Burhan
    Bhat, Geetha
    Yost, Gardner
    Tatooles, Antone
    ARTIFICIAL ORGANS, 2015, 39 (12) : 1046 - 1050
  • [28] Young Patients With Nonischemic Cardiomyopathy Have Higher Likelihood of Left Ventricular Recovery During Left Ventricular Assist Device Support
    Goldstein, Daniel J.
    Maybaum, Simon
    MacGillivray, Thomas E.
    Moore, Stephanie A.
    Bogaev, Roberta
    Farrar, David J.
    Frazier, O. Howard
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (05) : 392 - 395
  • [29] Changes in QT interval and action potential duration during and after left ventricular assist device (LVAD) induced recovery
    Hardy, J
    Terracciano, C
    Tansley, P
    Birks, E
    Bowles, C
    Khaghani, A
    Banner, N
    Yacoub, M
    HEART, 2004, 90 : A50 - A51
  • [30] Resting and 24-hour electrocardiographic changes during left ventricular assist device support
    Drakos, Stavros G.
    Anastasiou-Nana, Maria
    Charitos, Efstratios I.
    Ntalianis, Anargiros
    Venetsanakos, Ioannis
    Maroulidis, Georgios
    Lazaris, Nikolaus
    Theodoropoulos, Stergios
    Nanas, John N.
    Yacoub, Magdi H.
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S48 - S48